The popular "Hot Topics" newsletter from the American Acne and Rosacea Society (AARS) is now available as a podcast. Listen in for the latest updates on acne, rosacea, and hidradenitis suppurativa and the most recent developments from the Society.
Mix & Match: Assessing Concomitant Use of Newer Topical Formulations
Combination therapy is arguably the norm in acne care, but what do we know about the concomitant use of newer topical treatments? AARS Treasurer Emmy Graber, MD discusses findings from her recent study. The American Acne and Rosacea Society (AARS) is the only professional society focused on acne, hidradenitis suppurativa, and rosacea. Support AARS by becoming a member!
25 Mar 2025
Antibiotics, Diet, and Other Updates from the AAD Annual Meeting 2025
This special edition of the AARS Hot Topics Podcast features updates from Howa Yeung, MD, Lauren Kole, MD, Hilary Baldwin, MD, and Benjamin Ungar, MD, speaking from the Annual Meeting of the American Academy of Dermatology. They offer updates on safe use of antibiotics, emerging strategies for patient care, and the influence of diet in acne and rosacea. The American Acne and Rosacea Society (AARS) is the only professional society focused on acne, hidradenitis suppurativa, and rosacea....
24 Feb 2025
Shedding Light on Devices for Acne: Update from Emmy Graber, MD
There are energy-based devices approved for the treatment of acne plus others with promising data. But there is some confusion about what works and what doesn't. AARS Treasurer Emmy Graber, MD provides an overview of findings from a recent study. The American Acne and Rosacea Society (AARS) is the only professional society focused on acne, hidradenitis suppurativa, and rosacea. Support AARS by becoming a member!
16 Jan 2025
What to Know About Bimekizumab for HS: Update from James Q. Del Rosso, DO
AARS President James Q. Del Rosso, DO, provides an update on key data considerations for bimekizumab, a newly approved treatment for hidradenitis suppurativa.
12 Dec 2024
Laboratory Testing for Patients Taking Isotretinoin for Acne: Insights from Jonathan Weiss, MD
AARS President Elect Jonathan Weiss, MD, FAAD, shares insights on optimal laboratory testing for patients taking isotretinoin for acne, aligning expert thinking with American Academy of Dermatology guidelines.
13 Nov 2024
Cannabis-Related Product Use Among Patients with Hidradenitis Suppurativa: Insights from Adam Friedman, MD
New research offers new insights on the use of cannabis among patients with hidradenitis suppurativa. The findings don't surprise Adam Friedman, MD, Professor and Chair of Dermatology and Director of the HS program at GW School of Medicine and Health Sciences. He shares his insights on the paper, published in the Journal of Cutaneous Medicine and Surgery, and offers tips for counseling and managing patients. Dr. Friedman is a Director of the American Acne and Rosacea Society. The America...
26 Aug 2024
Hot Topics August 15, 2024: HS Updates, Emergency Contraception and Isotretinoin
In a new AARS video dermatologist Andrea Zaenglein, MD, FAAD and OB/Gyn Sarah K. Horvath, MD, MSHP, FACOG discuss patient counseling and recommendations for prescribing emergency contraception for patients on isotretinoin. Crown Laboratories, which owns the PanOxyl line of acne care products, plans to acquire Revance Therapeutics. New data for izokibep, a novel IL-17A inhibitor, for HS, and more.The American Acne and Rosacea Society (AARS) is the only professional society focused on acne, hid...
6 Jun 2024
Hot Topics June 6 2024: Highlights from the 11th Annual AARS Scientific Symposium
As part of its ongoing efforts to support research and share scientific knowledge about acne, hidradenitis suppurativa (HS), and rosacea, the American Acne and Rosacea Society (AARS) hosted its 11th Annual Scientific Symposium on May 15, 2024. The AARS was thrilled to welcome the attendees of the annual Society for Investigative Dermatology meeting to hear researchers from across the US present recent advancements in dermatological research focusing on acne, HS, and rosacea. Plus, this edition of Hot Topics in print covers a new study comparing clascoterone with retinoids and new data from the BE HEARD I and BE HEARD II studies of bimekizumab in HS.
24 Apr 2024
Hot Topics April 16 2024: Welcome the New Board of Directors
Dr. Andrea Zaenglein was recognized at the 17th Annual AARS Networking Reception in San Diego last month, as she concluded her term as AARS President. Incoming President Dr. Jim Del Rosso. Other new officers and Directors have been announced. AARS leadership past and present was well represented from the podium at the Annual Meeting of the American Academy of Dermatology (AAD) in San Diego in March. Among those presenting was Valerie Callender, MD, whose session “Lasers and Energy Devices in the Treatment of Acne” were spotlighted in Derm World Meeting News. Learn about some of the latest important research in acne, rosacea, and HS while interacting with some of the brightest young minds in the field and AARS leadership on Wednesday, May 15, 2024 from 11:00 AM –1:00 PM at the 11th Annual AARS Scientific Symposium at the 81st Annual Meeting of the Society for Investigative Dermatology at the Hilton Anatole in Dallas, Texas. Chaired by Dr. Lawrence Eichenfield. The AARS mission is to promote, support, develop and provide an educational forum for the exchange of information related to acne/HS and rosacea and to fund clinical research opportunities for dermatology professionals who strive to improve the care of patients who suffer from acne and rosacea. The deadline to submit applications is Friday, May 31, 2024.
Podcast Authority Score: 6 / 100
A composite of feed quality, social presence, YouTube performance and engagement. Read the methodology.
Quality
2
Social presence
0
YouTube
0
Engagement
27
Contact AARS Hot Topics
Guest appearances
Does not typically book guests
Based on episode analysis; this does not confirm that the show is currently accepting guests.
Host of AARS Hot Topics?
Claim your podcast to manage its listing and keep your show details accurate.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine
